KR100786122B1 - 생약 추출물을 함유하는 비만억제 및 치료용 조성물 - Google Patents
생약 추출물을 함유하는 비만억제 및 치료용 조성물 Download PDFInfo
- Publication number
- KR100786122B1 KR100786122B1 KR1020060113784A KR20060113784A KR100786122B1 KR 100786122 B1 KR100786122 B1 KR 100786122B1 KR 1020060113784 A KR1020060113784 A KR 1020060113784A KR 20060113784 A KR20060113784 A KR 20060113784A KR 100786122 B1 KR100786122 B1 KR 100786122B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- obesity
- extract
- gypsum
- herbal
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 25
- 208000008589 Obesity Diseases 0.000 title claims abstract description 24
- 235000020824 obesity Nutrition 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 title abstract description 12
- 229940079593 drug Drugs 0.000 title abstract description 9
- 239000000284 extract Substances 0.000 title abstract description 8
- 238000011282 treatment Methods 0.000 title description 4
- 230000002265 prevention Effects 0.000 title 1
- 239000010440 gypsum Substances 0.000 claims abstract description 15
- 229910052602 gypsum Inorganic materials 0.000 claims abstract description 15
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 10
- 239000012676 herbal extract Substances 0.000 claims description 15
- 210000004207 dermis Anatomy 0.000 claims description 8
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 7
- 241000202807 Glycyrrhiza Species 0.000 claims description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 7
- 230000003579 anti-obesity Effects 0.000 claims description 7
- 229940010454 licorice Drugs 0.000 claims description 7
- 235000013527 bean curd Nutrition 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 4
- 230000001225 therapeutic effect Effects 0.000 claims description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- 240000000171 Crataegus monogyna Species 0.000 claims 2
- 238000010521 absorption reaction Methods 0.000 abstract description 8
- 235000019789 appetite Nutrition 0.000 abstract description 6
- 230000036528 appetite Effects 0.000 abstract description 6
- 235000019626 lipase activity Nutrition 0.000 abstract description 5
- 230000003247 decreasing effect Effects 0.000 abstract description 4
- 230000005764 inhibitory process Effects 0.000 abstract description 4
- 241000509537 Alisma canaliculatum Species 0.000 abstract 1
- 235000008658 Artemisia capillaris Nutrition 0.000 abstract 1
- 241000092668 Artemisia capillaris Species 0.000 abstract 1
- 241000202722 Bupleurum falcatum Species 0.000 abstract 1
- 241000555678 Citrus unshiu Species 0.000 abstract 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 abstract 1
- 241000657480 Crataegus pinnatifida Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 241001522232 Pinellia ternata Species 0.000 abstract 1
- 230000008030 elimination Effects 0.000 abstract 1
- 238000003379 elimination reaction Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 22
- 238000012360 testing method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 230000002366 lipolytic effect Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000018823 dietary intake Nutrition 0.000 description 6
- 241001092040 Crataegus Species 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 241000411851 herbal medicine Species 0.000 description 5
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 5
- 229960001243 orlistat Drugs 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013376 functional food Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000002651 drug therapy Methods 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 210000004003 subcutaneous fat Anatomy 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- UYXTWWCETRIEDR-UHFFFAOYSA-N Tributyrin Chemical compound CCCC(=O)OCC(OC(=O)CCC)COC(=O)CCC UYXTWWCETRIEDR-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000000883 anti-obesity agent Substances 0.000 description 2
- 229940125710 antiobesity agent Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 238000009207 exercise therapy Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000002489 hematologic effect Effects 0.000 description 2
- 239000002960 lipid emulsion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003880 negative regulation of appetite Effects 0.000 description 2
- 229940006347 orlistat 120 mg Drugs 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- 201000009487 Amblyopia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000007791 dehumidification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 235000005523 excessive nutrition Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 208000003532 hypothyroidism Diseases 0.000 description 1
- 230000002989 hypothyroidism Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 231100000668 minimum lethal dose Toxicity 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- -1 neurostabilizers Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229940127234 oral contraceptive Drugs 0.000 description 1
- 239000003539 oral contraceptive agent Substances 0.000 description 1
- 230000005813 organ abnormality Effects 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 208000001162 steatorrhea Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
- A61K36/8994—Coix (Job's tears)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Botany (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (4)
- 진피, 의이인, 산사, 시호, 인진, 택사, 두충, 감초, 및 반하를 포함하는 생약 혼합물에서 추출되는 생약복합 추출물을 함유하는 것을 특징으로 하는 비만억제 및 치료용 조성물.
- 제 1항에 있어서, 상기 생약 혼합물은 석고 침출수의 상등액 건조물을 더 포함하는 것을 특징으로 하는 비만억제 및 치료용 조성물.
- 제 1항에 있어서, 상기 생약 혼합물은 진피 17 내지 23중량 %, 의이인 17 내지 23중량 %, 산사 17 내지 23중량 %, 시호 8 내지 12중량 %, 인진 8 내지 12중량 %, 택사 8 내지 12중량 %, 두충 2 내지 6 중량 %, 감초 2 내지 6 중량 %, 및 반하 1 내지 3 중량 %를 포함하는 것을 특징으로 하는 비만억제 및 치료용 조성물.
- 제 3항에 있어서, 상기 생약 혼합물은 석고 1 내지 3중량 %를 더 포함하는 것을 특징으로 하는 비만억제 및 치료용 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060113784A KR100786122B1 (ko) | 2006-11-17 | 2006-11-17 | 생약 추출물을 함유하는 비만억제 및 치료용 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060113784A KR100786122B1 (ko) | 2006-11-17 | 2006-11-17 | 생약 추출물을 함유하는 비만억제 및 치료용 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100786122B1 true KR100786122B1 (ko) | 2007-12-21 |
Family
ID=39147125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060113784A KR100786122B1 (ko) | 2006-11-17 | 2006-11-17 | 생약 추출물을 함유하는 비만억제 및 치료용 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100786122B1 (ko) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014035035A1 (ko) * | 2012-08-28 | 2014-03-06 | (주)뉴메드 | 산사 및 진피의 복합 추출물을 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 약학 조성물 |
KR102001557B1 (ko) * | 2018-11-30 | 2019-07-17 | 메디케어제약 주식회사 | 인진호 및 진피 복합추출물을 유효성분으로 함유하는 대사성 질환 예방 또는 치료용 조성물 |
KR20200060040A (ko) * | 2018-11-22 | 2020-05-29 | 경희대학교 산학협력단 | 포공영 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR20200060041A (ko) * | 2018-11-22 | 2020-05-29 | 경희대학교 산학협력단 | 반하 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR20200098201A (ko) * | 2019-02-12 | 2020-08-20 | (주)보인바이오컨버젼스 | 생약추출물을 유효성분으로 포함하는 국소 지방 분해용 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030075067A (ko) * | 2002-03-15 | 2003-09-22 | 조명하 | 진피 복합제를 이용한 비만 치료제 조성물 추출방법 |
KR20050078868A (ko) * | 2004-02-03 | 2005-08-08 | 제일약품주식회사 | 비만의 예방 및 치료용 조성물 |
-
2006
- 2006-11-17 KR KR1020060113784A patent/KR100786122B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20030075067A (ko) * | 2002-03-15 | 2003-09-22 | 조명하 | 진피 복합제를 이용한 비만 치료제 조성물 추출방법 |
KR20050078868A (ko) * | 2004-02-03 | 2005-08-08 | 제일약품주식회사 | 비만의 예방 및 치료용 조성물 |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014035035A1 (ko) * | 2012-08-28 | 2014-03-06 | (주)뉴메드 | 산사 및 진피의 복합 추출물을 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 약학 조성물 |
KR101415697B1 (ko) * | 2012-08-28 | 2014-07-04 | (주)뉴메드 | 산사 및 진피의 복합 추출물을 유효성분으로 함유하는 비만 또는 지질 관련 대사성 질환의 치료 또는 예방용 약학 조성물 |
KR20200060040A (ko) * | 2018-11-22 | 2020-05-29 | 경희대학교 산학협력단 | 포공영 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR20200060041A (ko) * | 2018-11-22 | 2020-05-29 | 경희대학교 산학협력단 | 반하 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR102163181B1 (ko) | 2018-11-22 | 2020-10-08 | 경희대학교 산학협력단 | 반하 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR102231324B1 (ko) | 2018-11-22 | 2021-03-24 | 경희대학교 산학협력단 | 포공영 추출물을 유효성분으로 포함하는 지방 분해용 조성물 |
KR102001557B1 (ko) * | 2018-11-30 | 2019-07-17 | 메디케어제약 주식회사 | 인진호 및 진피 복합추출물을 유효성분으로 함유하는 대사성 질환 예방 또는 치료용 조성물 |
US11285188B2 (en) | 2018-11-30 | 2022-03-29 | Medicare Pharmaceuticals Inc. | Composition for preventing or treating metabolic diseases containing artemisiae capillaris herba and citrus unshiu peel complex extracts as active ingredients |
KR20200098201A (ko) * | 2019-02-12 | 2020-08-20 | (주)보인바이오컨버젼스 | 생약추출물을 유효성분으로 포함하는 국소 지방 분해용 조성물 |
WO2020166773A1 (ko) * | 2019-02-12 | 2020-08-20 | (주)보인바이오컨버젼스 | 생약추출물을 유효성분으로 포함하는 국소 지방 분해용 조성물 |
KR102199536B1 (ko) | 2019-02-12 | 2021-01-07 | (주)보인바이오컨버젼스 | 생약추출물을 유효성분으로 포함하는 국소 지방 분해용 조성물 |
CN113194973A (zh) * | 2019-02-12 | 2021-07-30 | 补人生物融合股份有限公司 | 包含生药提取物作为有效成分的用于分解局部脂肪的组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103355556A (zh) | 一种玉米型断奶仔猪配合饲料及其制备方法 | |
KR20110027717A (ko) | 1,3/1,6 베타 글루칸을 포함하는 체중 감량용 조성물 | |
KR100786122B1 (ko) | 생약 추출물을 함유하는 비만억제 및 치료용 조성물 | |
CN110075216B (zh) | 一种具有辅助降血脂、减肥保肝作用的食品组合物及其制备方法、制剂与应用 | |
CN103721103B (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
KR100516180B1 (ko) | 항고지혈증 조성물 | |
CN104225417A (zh) | 一种辅助改善记忆力功能的中药组合物及其制备方法 | |
EP1583547B1 (en) | Anti-obesity ingredients from medicinal plants and their composition | |
KR100678519B1 (ko) | 다슬기, 유황오리, 유근피, 송화가루, 산청목, 죽염,인진쑥, 도라지 및 흑두로 구성되는 복합제 추출물을포함하는 지방간 예방 및 치료를 위한 조성물 | |
CN110772564A (zh) | 一种具有调节抑郁情绪作用的中药提取物组合物及其制备方法和中药制剂 | |
KR100733984B1 (ko) | 한약재와 곤약을 이용한 비만 또는 고지혈증의 치료 및 예방용 약제학적 조성물 | |
CN110051817A (zh) | 一种降低尿酸的中药组合及其应用 | |
KR101511364B1 (ko) | 복합 생약재를 이용한 비만 및 대사증후군의 예방 또는치료용 조성물 | |
KR20200081553A (ko) | 진해거담 예방 및 개선용 조성물 | |
CN108498568A (zh) | 用羊胎盘或胚胎治疗自体免疫性与免疫相关性疾病的中成药、医用食品及制备方法 | |
CN103719552B (zh) | 用于防治猪丹毒的饲料及其制备方法 | |
CN113476564A (zh) | 一种具有降脂作用的组合物 | |
CN108159204B (zh) | 一种具有解毒保肝作用的藏药组合物 | |
KR101908850B1 (ko) | 구기자를 포함하는 항비만 한방조성물 및 그 제조방법 | |
CN101143203A (zh) | 一种具有护肝养胃功能的复方口服液 | |
JP4610730B2 (ja) | カルシウム補給用の組成物 | |
KR100532556B1 (ko) | 솔잎, 녹차 및 홍차 추출물을 유효성분으로 함유하는 비만및 변비 치료용 조성물 | |
CN100566739C (zh) | 含有三七、杜仲和西洋参的组合物 | |
JPH06107553A (ja) | 鎮痛機能を有する組成物 | |
CN103610991B (zh) | 用于治疗猪胃溃疡的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121211 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20131114 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20141117 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150724 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20161012 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170810 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180503 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190814 Year of fee payment: 13 |